×
About 350 results

ALLMedicine™ Allergy Immunotherapy Center

Research & Reviews  110 results

Allergy, Immunotherapy, and Alternative Treatments for Dizziness.
https://doi.org/10.1016/j.otc.2021.05.020
Otolaryngologic Clinics of North America; Derebery MJ, Christopher L

Jul 24th, 2021 - Allergic reactions may result in central symptoms of dizziness, including nonspecific chronic imbalance, Meniere's disease, and autoimmune inner ear disease. Excepting first-generation antihistamines, and short-term use of steroids, most pharmacot...

Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national h...
https://doi.org/10.2500/aap.2021.42.210035
Allergy and Asthma Proceedings; Winders T, DuBuske L et. al.

May 26th, 2021 - Background: Most U.S. patient and health care provider surveys with regard to nasal allergy treatments were conducted before sublingual immunotherapy (SLIT)-tablets and allergy immunotherapy (AIT) shared decision-making tools were available. Objec...

Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commerc...
https://doi.org/10.1080/03007995.2021.1903848
Current Medical Research and Opinion; Tkacz JP, Rance K et. al.

Mar 24th, 2021 - To assess total and allergic rhinitis (AR)-related healthcare costs among AR patients residing in the United States with a focus on patients persisting with AIT. AR patients were identified in the IBM MarketScan database between 1 January 2014 to ...

Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy.
https://doi.org/10.1080/1744666X.2021.1886079
Expert Review of Clinical Immunology; Cox L

Mar 2nd, 2021 - Introduction: The purpose of this review is to evaluate the cost-effectiveness of allergy immunotherapy (AIT) in the treatment of allergic rhinitis, asthma, and other allergic conditions.Area covered: An extensive search of the PubMed and Medline ...

A randomized trial of subcutaneous allergy immunotherapy in inner-city children with as...
https://doi.org/10.1016/j.anai.2020.12.016
Annals of Allergy, Asthma & Immunology : Official Publica... de Vos G, Viswanathan S et. al.

Jan 9th, 2021 - Allergic sensitization to environmental allergens in the first years of life is a strong predictor of asthma morbidity in children. Allergy immunotherapy can improve asthma and allergy outcomes, but its efficacy in inner-city, atopic children of l...

see more →

Clinicaltrials.gov  4 results

Microassay and Allergy Skin Prick Test Correlation Study
https://clinicaltrials.gov/ct2/show/NCT03514303

Oct 17th, 2018 - Prospective subjects for study entry will initially be screened by the results of their allergy skin test that were acquired within the past two years. In order to be a prospective subject positive SPT results of five of the following ten allergen...

Allergy Immunotherapy for the Reduction of Asthma
https://clinicaltrials.gov/ct2/show/NCT01028560

Jul 12th, 2018 - In this clinical study we aim to determine the effect of allergy immunotherapy in decreasing asthma and allergy related disease in children who had multiple episodes of wheezing and who are at high risk for developing persisting asthma. These risk...

Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
https://clinicaltrials.gov/ct2/show/NCT00405899

May 31st, 2010 - This study will consist of five visits. Visit 1 will occur after subjects complete an initial clinical evaluation for allergy at this site. Subjects will select their treatment (allergy immunotherapy as compared to standard medical care) prior to ...

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
https://clinicaltrials.gov/ct2/show/NCT02014623

Allergic diseases represent a major health issue worldwide and epidemiological studies in Melbourne, Australia, have reported a high prevalence of rhinitis (hayfever) and atopy (genetic tendency to make allergy antibody) in Asian and Caucasian sub...

see more →

News  26 results

There's a Much Safer Food Allergy Immunotherapy. Why Don't More Doctors Offer It?
https://www.medscape.com/viewarticle/954302

Jul 7th, 2021 - This is part 1 of a three-part series. Part 2 is here. Part 3 is here. For the 32 million people in the United States with food allergies, those who seek relief beyond constant vigilance and EpiPens face a confusing treatment landscape. In January...

FDA-Approved Peanut Immunotherapy Protocol Comes With a Cost
https://www.medscape.com/viewarticle/941016

Nov 15th, 2020 - Peanut allergy immunotherapy now comes with approval from the US Food and Drug Administration (FDA), but it also comes with protocols, standards, and paperwork. Whether it will be widely adopted has yet to be determined. A few dozen allergists aro...

Don't Endanger Your Patients: Stop Allergy Immunotherapy Now
https://www.medscape.com/viewarticle/928035

Apr 6th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

Don't Endanger Your Patients: Stop Allergy Immunotherapy Now
https://www.staging.medscape.com/viewarticle/928035

Apr 6th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

Allergy immunotherapy may modify asthma severity progression
https://www.mdedge.com/chestphysician/article/208885/asthma/allergy-immunotherapy-may-modify-asthma-severity-progression?channel=188
Mark S. Lesney, MDedge News

Sep 26th, 2019 - The use of a grass-based allergy immunotherapy (AIT) lowered the risk of progression from milder to more severe asthma, according to the results of a large, real-world, industry-sponsored, observational study. Photo courtesy Oak Ridge National Lab.

see more →